Genfit, Bicoll GmbH, Merck KGaA, University of Freiburg deal

Genfit partnered with Bicoll and the university to discover ligands for undisclosed orphan nuclear receptors to treat cardiovascular and metabolic diseases. The 2.5-year deal will be sponsored by EurotransBio, which is an industry development consortium consisting of public funding agencies from Austria, Finland, France, Germany, the Netherlands and Spain.

Separately, Genfit partnered with MRK to validate an undisclosed class of therapeutics for diabetes and insulin resistance. The three-year deal will be partially funded by the EC's Corporate Competitiveness Fund. ...